Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...

Six Proto6 flaws in protobuf.js enable RCE and DoS attacks; patched in versions 7.5.6 and 8.0.2 to protect Node.js services.

“But full recursive self-improvement also might increase the risks of humans losing control over AI systems,” it warns adding “If systems are capable of fully building their own successors, the ways ...

Boris Cherny was asked at Brainstorm Tech if he was concerned about the rapid progress of AI: "Yes." ...

States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts ...

2026年6月4日，美国AI公司Anthropic发表文章《When AI Builds Itself》，呼吁顶级人工智能实验室考虑放慢开发步伐，称AI正以极快的速度发展，可能很快就能在无人干预的情况下进行自我完善，或对社会构成重大风险。